PatientsVille.com Logo

PatientsVille

Etoricoxib Side Effects

Common Etoricoxib Side Effects


The most commonly reported Etoricoxib side effects (click to view or check a box to report):

Transient Ischaemic Attack (3)
Gastroenteritis Eosinophilic (2)
Hypersensitivity (2)
Breast Cancer (2)
Asthenia (2)
Ileus (2)
Dyspnoea (2)
Nausea (2)
Tachycardia (2)
Vomiting (2)
Pyrexia (2)
Sjogren's Syndrome (2)
Oedema Peripheral (1)
Melaena (1)
Loss Of Consciousness (1)
Pulmonary Oedema (1)
Pancreatitis Acute (1)
Oesophagitis (1)
Pigmentation Disorder (1)
Productive Cough (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Etoricoxib Side Effects Reported to FDA

The following Etoricoxib reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Etoricoxib on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Urticaria
This is a report of a 51-year-old female patient (weight: NA) from IT, suffering from the following symptoms/conditions: NA, who was treated with Etoricoxib (dosage: 45 Mg, Unk, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Urticaria
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Etoricoxib treatment in female patients, resulting in urticaria side effect.

Loss Of Consciousness, Tachycardia, Pyrexia
This report suggests a potential Etoricoxib Loss Of Consciousness, Tachycardia, Pyrexia side effect(s) that can have serious consequences. A 20-year-old female patient (weight: NA) from UA was diagnosed with the following symptoms/conditions: pain and used Etoricoxib (dosage: Unk) starting 2013. Soon after starting Etoricoxib the patient began experiencing various side effects, including:
  • Loss Of Consciousness
  • Tachycardia
  • Pyrexia
Drugs used concurrently:
  • Lincomycin (Unk)
  • Claritine (Unk)
Although Etoricoxib demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as loss of consciousness, may still occur.

Acute Myocardial Infarction
This Acute Myocardial Infarction problem was reported by a physician from UNITED KINGDOM. A 64-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: osteoarthritis. On Jan 22, 2009 this consumer started treatment with Etoricoxib (dosage: 90 Mg, 1x/day). The following drugs were being taken at the same time:
  • Piroxicam (20 Mg, 1x/day)
When commencing Etoricoxib, the patient experienced the following unwanted symptoms/side effects:
  • Acute Myocardial Infarction
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as acute myocardial infarction, may become evident only after a product is in use by the general population.

Stevens-johnson Syndrome, Toxic Epidermal Necrolysis, Pigmentation Disorder
This is a report of a 30-year-old male patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Etoricoxib (dosage: NA) starting NS. Concurrently used drugs:
  • Penicillin V
  • Metamizole
Soon after that, the consumer experienced the following side effects:
  • Stevens-johnson Syndrome
  • Toxic Epidermal Necrolysis
  • Pigmentation Disorder
The patient was hospitalized. This opens a possibility that Etoricoxib treatment could cause the above reactions, including stevens-johnson syndrome, and some male subjects may be more susceptible.


White Blood Cell Count Decreased
A 57-year-old female patient (weight: NA) from MALAYSIA with the following symptoms/conditions: rheumatoid arthritis,diabetes mellitus started Etoricoxib treatment (dosage: NA) on NS. Soon after starting Etoricoxib treatment, the subject experienced various side effects, including:
  • White Blood Cell Count Decreased
Concurrently used drugs:
  • Metformin Hcl (1gm Bd)
  • Methotrexate
  • Humira
  • Calcitriol
This finding indicates that some female patients could be more vulnerable to Etoricoxib.

Ear Pain, Trismus, Weight Increased, Ear Neoplasm, Amnesia
A female patient from BRAZIL (weight: NA) experienced symptoms, such as: rheumatoid arthritis and was treated with Etoricoxib(dosage: 1 Tablet In The Morning). The treatment was initiated on Jan 01, 2003. After that a consumer reported the following side effect(s):
  • Ear Pain
  • Trismus
  • Weight Increased
  • Ear Neoplasm
  • Amnesia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Etoricoxib efficacy:
  • Methotrexate (1 Tablet Per Week)
  • Humira
  • Amlodipine (1 Tablet In The Morning)
  • Captopril (1 Tablet In The Evening)
  • Methotrexate
  • Levothyroxine Sodium (1 Tablet In The Morning)
  • Atenolol
  • Amitriptyline Hcl (1 Tablet In The Evening)


Dizziness, Erythema, Angioedema, Nausea
In this report, Etoricoxib was administered for the following condition: pyrexia.A 40-year-old male consumer from SINGAPORE (weight: NA) started Etoricoxib treatment (dosage: NA) on Dec 30, 2011.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Dizziness
  • Erythema
  • Angioedema
  • Nausea
A possible interaction with other drugs could have contributed to this reaction:
  • Zyrtec-d 12 Hour
  • Loratadine
  • Pseudoephedrine Hcl
  • Zyrtec-d 12 Hour
  • Pseudoephedrine Hcl
Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Etoricoxib treatment could be related to the listed above side effect(s).

Pancreatitis Acute
This is a report of the following Etoricoxib side effect(s):
  • Pancreatitis Acute
A 42-year-old female patient from UNITED KINGDOM (weight: NA) presented with the following condition: NA and received a treatment with Etoricoxib (dosage: 1 Tab, Qd) starting: Nov 22, 2011.The following concurrently used drugs could have generated interactions:
  • Metformin Hcl (1000 Mg, Qd)
  • Victoza (1.2 Mg, Qd)
  • Methotrexate (20 Mg, Unk)
  • Glimepirid (2 Mg, Qd)
  • Ranitidine (150 Unk, Unk)
  • Amitriptyline Hcl (50 Unk, Unk)
  • Acetaminophen And Codeine Phosphate
  • Dihydrocodeine Bitartrate Inj
The patient was hospitalized.This report suggests that a Etoricoxib treatment could be associated with the listed above side effect(s).

Cellulitis, Skin Reaction
This Etoricoxib report was submitted by a 54-year-old female consumer from TAIWAN, PROVINCE OF CHINA (weight: NA). The patient was diagnosed with: pain and Etoricoxib was administered (dosage: NA) starting: Apr 24, 2009. The consumer developed a set of symptoms:
  • Cellulitis
  • Skin Reaction
Other drugs used simultaneously:
  • Ultracet (1 Tablet Twice A Day)
The patient was hospitalized.Those unexpected symptoms could be linked to a Etoricoxib treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Back Pain, Dyspnoea, Hypersensitivity, Sjogren's Syndrome
This is a report of a possible correlation between Etoricoxib use and the following symptoms/side effect(s):
  • Back Pain
  • Dyspnoea
  • Hypersensitivity
  • Sjogren's Syndrome
which could contribute to an assessment of Etoricoxib risk profile.A 56-year-old female consumer from COLOMBIA (weight: NA) was suffering from arthralgia,multiple sclerosis and was treated with Etoricoxib (dosage: NA) starting Apr 01, 2011.Other concurrent medications:
  • Tysabri


Breast Cancer
A female patient from GERMANY (weight: NA) presented with the following symptoms: rheumatoid arthritis and after a treatment with Etoricoxib (dosage: NA) experienced the following side effect(s):
  • Breast Cancer
The treatment was started on Aug 09, 2011. Etoricoxib was used in combination with the following drugs:
  • Prednisolone
  • Humira (Eow)
The patient was hospitalized.This report could alert potential Etoricoxib consumers.

Oedema Peripheral, Lip Swelling, Hypersensitivity
In this report, a 71-year-old female patient from UNITED KINGDOM (weight: NA) was affected by a possible Etoricoxib side effect.The patient was diagnosed with NA. After a treatment with Etoricoxib (dosage: Unk, start date: Oct 13, 2011), the patient experienced the following side effect(s):
  • Oedema Peripheral
  • Lip Swelling
  • Hypersensitivity
The following simultaneously used drugs could have led to this reaction:
  • Oramorph Sr (Unk)
  • Lansoprazole (Unk)
  • Methotrexate (Unk)
  • Levothyroxine Sodium (Unk)
  • Duragesic-100 (Unk)
  • Enbrel (50 Mg, Unk)
The findings here stress that side effects should be taken into consideration when evaluating a Etoricoxib treatment.

Sjogren's Syndrome
This is a report of a 56-year-old female patient from COLOMBIA (weight: NA), who used Etoricoxib (dosage: NA) for a treatment of arthralgia,multiple sclerosis. After starting a treatment on Apr 01, 2011, the patient experienced the following side effect(s):
  • Sjogren's Syndrome
The following drugs could possibly have interacted with the Etoricoxib treatment
  • Tysabri
Taken together, these observations suggest that a Etoricoxib treatment could be related to side effect(s), such as Sjogren's Syndrome.

Toxic Encephalopathy
This toxic encephalopathy side effect was reported by a health professional from FRANCE. A 58-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Etoricoxib (dosage: NA), which was started on Aug 05, 2011. Concurrently used drugs:
  • Furosemide
  • Metfformin Hydrochloride
  • Potassium Chloride
  • Amlodipine Besylate
  • Propranolol Hydrochloride
  • Metfformin Hydrochloride
  • Allopurinol
  • Spironolactone
When starting to take Etoricoxib the consumer reported the following symptoms:
  • Toxic Encephalopathy
The patient was hospitalized. These side effects may potentially be related to Etoricoxib.

Chills, Vertigo, Dyspnoea, Fatigue, Pyrexia, Abdominal Pain Upper, Nausea, Productive Cough
This is a Etoricoxibum side effect report of a male patient (weight:NA) from ROMANIA, suffering from the following symptoms/conditions: NA, who was treated with Etoricoxibum (dosage:Cox-2 Inhibitor, start time: Aug 20, 2010), combined with:
  • Quinaprilum
  • Humira
  • Sulfasalazinum (Dmard)
  • Simvastatinum
  • Betaxololum
, and developed a serious reaction and a chills side effect. The patient presented with:
  • Chills
  • Vertigo
  • Dyspnoea
  • Fatigue
  • Pyrexia
  • Abdominal Pain Upper
  • Nausea
  • Productive Cough
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Etoricoxibum treatment in male patients suffering from NA, resulting in chills.

Renal Failure, Kidney Fibrosis
This report suggests a potential Etoricoxib renal failure side effect(s) that can have serious consequences. A 60-year-old female patient from ISRAEL (weight:NA) was diagnosed with the following health condition(s): NA and used Etoricoxib (dosage: NA) starting NS. Soon after starting Etoricoxib the patient began experiencing various side effects, including:
  • Renal Failure
  • Kidney Fibrosis
Drugs used concurrently:
  • Furosemide (40-60mg)
  • Orlistat
The patient was hospitalized. Although Etoricoxib demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as renal failure, may still occur.

Melaena, Duodenal Ulcer, Haemoglobin Decreased
This melaena problem was reported by a health professional from UNITED KINGDOM. A 74-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): osteoarthritis,thrombosis prophylaxis.On May 02, 2011 a consumer started treatment with Etoricoxib (dosage: NA). The following drugs/medications were being taken at the same time:
  • Enoxaparin Sodium
  • Ibuprofen
  • Alendronate Sodium
  • Calcichew D3
  • Levothyroxine Sodium
  • Acetaminophen
When commencing Etoricoxib, the patient experienced the following unwanted symptoms /side effects:
  • Melaena
  • Duodenal Ulcer
  • Haemoglobin Decreased
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as melaena, may become evident only after a product is in use by the general population.

Ileus, Gastroenteritis Eosinophilic, Eosinophilic Colitis, Ascites
This is a Etoricoxib (etoricoxib) (etoricoxib) side effect report of a 54-year-old female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Etoricoxib (etoricoxib) (etoricoxib) (dosage: NA) starting Nov 01, 2010. Concurrently used drugs:
  • Ramipril
  • Carvedilol
  • Torsemide (torasemide) (torasemide)
  • Roflumilast (roflumilast) (tablets) (500 Mcg (500 Mcg, 1 In 1 D), Oral)
  • Pantoprazole (pantoprazole) (pantoprazole)
Soon after that, the consumer experienced the following of symptoms:
  • Ileus
  • Gastroenteritis Eosinophilic
  • Eosinophilic Colitis
  • Ascites
The patient was hospitalized. This opens a possibility that Etoricoxib (etoricoxib) (etoricoxib) could cause ileus and that some female patients may be more susceptible.

Gastroenteritis Eosinophilic
A 54-year-old female patient (weight: NA) from GERMANY with the following symptoms: NA started Etoricoxib (etoricoxib)(etoricoxib) treatment (dosage: NA) on Nov 01, 2010. Soon after starting Etoricoxib (etoricoxib)(etoricoxib) treatment, the consumer experienced several side effects, including:
  • Gastroenteritis Eosinophilic
. Concurrently used drugs:
  • Pantoprazole (pantoprazole) (pantoprazole)
  • Torsemide (torasemide)(torasemide)
  • Ramipril
  • Roflumilast (roflumilast) (tablets) ((500 Mcg, 1 In 1 D),oral)
  • Carvedilol
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Etoricoxib (etoricoxib)(etoricoxib) side effects, such as gastroenteritis eosinophilic.

Rhinorrhoea, Acne, Rash, Basal Cell Carcinoma
This rhinorrhoea side effect was reported by a consumer or non-health professional from NETHERLANDS. A female patient (weight:NA) experienced the following symptoms/conditions: ankylosing spondylitis,vitamin supplementation,gastric disorder.The patient was prescribed Etoricoxib Film Coated (dosage: NA), which was started on Aug 01, 2010. Concurrently used drugs:
  • Folic Acid
  • Omeprazole
  • Humira
  • Acenocoumarol (As Per Regimen)
  • Levonorgestrel And Ethinyl Estradiol (30/150 Mcg)
  • Alendronic Acid
  • Rizaptriptan Fast Dissolving
  • Omeprazole
.When starting to take Etoricoxib Film Coated the consumer reported symptoms, such as:
  • Rhinorrhoea
  • Acne
  • Rash
  • Basal Cell Carcinoma
These side effects may potentially be related to Etoricoxib Film Coated.

Convulsion
This is a report of a 55-year-old female patient (weight: NA) from GERMANY, suffering from the following symptoms/conditions: back pain, who was treated with Etoricoxib (dosage: NA, start time: Dec 15, 2010), combined with:
  • Oxycodon
  • Pregabalin
  • Palexia
  • Flunitrazepam
and developed a serious reaction and side effect(s). The consumer presented with:
  • Convulsion
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Etoricoxib treatment in female patients, resulting in convulsion side effect.

Gastroenteritis
This report suggests a potential Etoricoxib Gastroenteritis side effect(s) that can have serious consequences. A 23-year-old female patient (weight: NA) from INDIA was diagnosed with the following symptoms/conditions: rheumatoid arthritis and used Etoricoxib (dosage: NA) starting NS. Soon after starting Etoricoxib the patient began experiencing various side effects, including:
  • Gastroenteritis
Drugs used concurrently: NA.The patient was hospitalized. Although Etoricoxib demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as gastroenteritis, may still occur.

Breast Cancer
This Breast Cancer problem was reported by a health professional from UNITED KINGDOM. A 41-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jun 03, 2008 this consumer started treatment with Etoricoxib (dosage: 25 Mg, Unk). The following drugs were being taken at the same time:
  • Enbrel (25 Mg, 2 Times/wk)
When commencing Etoricoxib, the patient experienced the following unwanted symptoms/side effects:
  • Breast Cancer
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as breast cancer, may become evident only after a product is in use by the general population.

Ileus, Cerebral Infarction
This is a report of a female patient (weight: NA) from GERMANY. The patient developed the following symptoms/conditions: NA and was treated with Etoricoxib (dosage: NA) starting Apr 19, 2007. Concurrently used drugs:
  • Mometasone Furoate (Mometasone Salve)
  • Vitalipid
  • Capecitabine
  • Irinotecan Hydrochloride (Dosage Form: Infusion.)
Soon after that, the consumer experienced the following side effects:
  • Ileus
  • Cerebral Infarction
The patient was hospitalized. This opens a possibility that Etoricoxib treatment could cause the above reactions, including ileus, and some female subjects may be more susceptible.

Respiratory Distress, Left Ventricular Hypertrophy, Heart Rate Decreased, Electrocardiogram Qrs Complex Prolonged, Sinus Bradycardia, Renal Failure Acute, Cardiac Failure Congestive, Pulmonary Oedema, Asthenia
A 75-year-old male patient (weight: NA) from INDIA with the following symptoms/conditions: back pain started Etoricoxib treatment (dosage: 90 Mg) on NS. Soon after starting Etoricoxib treatment, the subject experienced various side effects, including:
  • Respiratory Distress
  • Left Ventricular Hypertrophy
  • Heart Rate Decreased
  • Electrocardiogram Qrs Complex Prolonged
  • Sinus Bradycardia
  • Renal Failure Acute
  • Cardiac Failure Congestive
  • Pulmonary Oedema
  • Asthenia
Concurrently used drugs:
  • Ecospirin (75 Mg)
  • Insulin Mixtard (34 U/ 24 U)
  • Levothyroxine Sodium (50 Mcg)
  • Micardis Hct (40 Mg)
  • Torsemide (10 Mg)
  • Atorvastatin Calcium (10 Mg)
  • Nifedipine (40 Mg)
The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Etoricoxib.

1 of 2 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Etoricoxib Side Effects

    Did You Have a Etoricoxib Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Etoricoxib for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective